|
|
||||||||
Journal of General Virology, Vol 78, 2813-2820, Copyright © 1997 by Society for General Microbiology
ARTICLES |
MK Hasan, A Kato, T Shioda, Y Sakai, D Yu and Y Nagai
Department of Viral Infection, Institute of Medical Science, University of Tokyo, Japan.
A genetic engineering approach was made to generate a recombinant non- segmented negative-strand RNA virus, Sendai virus (SeV) of the family Paramyxoviridae, that expresses firefly luciferase. The DNA construct containing the entire open reading frame (ORF) of the luciferase gene followed by the SeV transcription stop and restart signals connected with the conserved intergenic three nucleotides was inserted immediately before the ORF of the viral 3'-proximal nucleocapsid (N) protein gene in a full-length SeV cDNA copy. After intracellular expression of full-length antigenomic transcripts from the engineered cDNA and of the viral n ucleocapsid protein and RNA polymerase from the respective plasmids, a recombinant SeV expressing luciferase activity at a high level was recovered, although the tendency of this particular reporter gene product to aggregate in cells made it difficult to estimate the maximum level of expression. The increase in genome length brought about by inserting 1728 nucleotides into the 15,384 nucleotide parental SeV was associated with reduced plaque size, slightly slower replication kinetics and a severalfold decrease in yield of the virus. The inserted luciferase gene was stably maintained after numerous rounds of replication by serial passages in chick embryos. These results indicate the potential utility of SeV as a novel expression vector.
This article has been cited by other articles:
![]() |
K. Nishimura, H. Segawa, T. Goto, M. Morishita, A. Masago, H. Takahashi, Y. Ohmiya, T. Sakaguchi, M. Asada, T. Imamura, et al. Persistent and Stable Gene Expression by a Cytoplasmic RNA Replicon Based on a Noncytopathic Variant Sendai Virus J. Biol. Chem., September 14, 2007; 282(37): 27383 - 27391. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takeda, Y. Nakatsu, S. Ohno, F. Seki, M. Tahara, T. Hashiguchi, and Y. Yanagi Generation of Measles Virus with a Segmented RNA Genome J. Virol., May 1, 2006; 80(9): 4242 - 4248. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Huang, S. Elankumaran, A. S. Yunus, and S. K. Samal A Recombinant Newcastle Disease Virus (NDV) Expressing VP2 Protein of Infectious Bursal Disease Virus (IBDV) Protects against NDV and IBDV J. Virol., September 15, 2004; 78(18): 10054 - 10063. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Inoue, Y. Tokusumi, H. Ban, T. Kanaya, M. Shirakura, T. Tokusumi, T. Hirata, Y. Nagai, A. Iida, and M. Hasegawa A New Sendai Virus Vector Deficient in the Matrix Gene Does Not Form Virus Particles and Shows Extensive Cell-to-Cell Spreading J. Virol., June 1, 2003; 77(11): 6419 - 6429. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Inoue, Y. Tokusumi, H. Ban, T. Kanaya, T. Tokusumi, Y. Nagai, A. Iida, and M. Hasegawa Nontransmissible Virus-Like Particle Formation by F-Deficient Sendai Virus Is Temperature Sensitive and Reduced by Mutations in M and HN Proteins J. Virol., March 1, 2003; 77(5): 3238 - 3246. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamada, N. Kaji, T. Odawara, J. Chiba, A. Iwamoto, and Y. Kitamura Proline 78 Is Crucial for Human Immunodeficiency Virus Type 1 Nef To Down-Regulate Class I Human Leukocyte Antigen J. Virol., December 20, 2002; 77(2): 1589 - 1594. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Neumann, M. A. Whitt, and Y. Kawaoka A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned? J. Gen. Virol., November 1, 2002; 83(11): 2635 - 2662. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kawana-Tachikawa, M. Tomizawa, J.-i. Nunoya, T. Shioda, A. Kato, E. E. Nakayama, T. Nakamura, Y. Nagai, and A. Iwamoto An Efficient and Versatile Mammalian Viral Vector System for Major Histocompatibility Complex Class I/Peptide Complexes J. Virol., October 25, 2002; 76(23): 11982 - 11988. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Wertz, R. Moudy, and L. A. Ball Adding Genes to the RNA Genome of Vesicular Stomatitis Virus: Positional Effects on Stability of Expression J. Virol., June 27, 2002; 76(15): 7642 - 7650. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kato, Y. Ohnishi, M. Hishiyama, M. Kohase, S. Saito, M. Tashiro, and Y. Nagai The Amino-Terminal Half of Sendai Virus C Protein Is Not Responsible for either Counteracting the Antiviral Action of Interferons or Down-Regulating Viral RNA Synthesis J. Virol., June 14, 2002; 76(14): 7114 - 7124. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kano, T. Matano, A. Kato, H. Nakamura, A. Takeda, Y. Suzaki, Y. Ami, K. Terao, and Y. Nagai Primary replication of a recombinant Sendai virus vector in macaques J. Gen. Virol., June 1, 2002; 83(6): 1377 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Masaki, Y. Yonemitsu, A. Yamashita, S. Sata, M. Tanii, K. Komori, K. Nakagawa, X. Hou, Y. Nagai, M. Hasegawa, et al. Angiogenic Gene Therapy for Experimental Critical Limb Ischemia: Acceleration of Limb Loss by Overexpression of Vascular Endothelial Growth Factor 165 but not of Fibroblast Growth Factor-2 Circ. Res., May 17, 2002; 90(9): 966 - 973. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ito, M. Takayama, K. Yamada, M. Sugiyama, and N. Minamoto Rescue of Rabies Virus from Cloned cDNA and Identification of the Pathogenicity-Related Gene: Glycoprotein Gene Is Associated with Virulence for Adult Mice J. Virol., October 1, 2001; 75(19): 9121 - 9128. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Huang, S. Krishnamurthy, A. Panda, and S. K. Samal High-level expression of a foreign gene from the most 3'-proximal locus of a recombinant Newcastle disease virus J. Gen. Virol., July 1, 2001; 82(7): 1729 - 1736. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shioda, E. E. Nakayama, Y. Tanaka, X. Xin, H. Liu, A. Kawana-Tachikawa, A. Kato, Y. Sakai, Y. Nagai, and A. Iwamoto Naturally Occurring Deletional Mutation in the C-Terminal Cytoplasmic Tail of CCR5 Affects Surface Trafficking of CCR5 J. Virol., April 1, 2001; 75(7): 3462 - 3468. [Abstract] [Full Text] |
||||
![]() |
A. A. Haller, T. Miller, M. Mitiku, and K. Coelingh Expression of the Surface Glycoproteins of Human Parainfluenza Virus Type 3 by Bovine Parainfluenza Virus Type 3, a Novel Attenuated Virus Vaccine Vector J. Virol., December 15, 2000; 74(24): 11626 - 11635. [Abstract] [Full Text] |
||||
![]() |
H.-O. Li, Y.-F. Zhu, M. Asakawa, H. Kuma, T. Hirata, Y. Ueda, Y.-S. Lee, M. Fukumura, A. Iida, A. Kato, et al. A Cytoplasmic RNA Vector Derived from Nontransmissible Sendai Virus with Efficient Gene Transfer and Expression J. Virol., July 15, 2000; 74(14): 6564 - 6569. [Abstract] [Full Text] |
||||
![]() |
T. AKAIKE, S. FUJII, A. KATO, J. YOSHITAKE, Y. MIYAMOTO, T. SAWA, S. OKAMOTO, M. SUGA, M. ASAKAWA, Y. NAGAI, et al. Viral mutation accelerated by nitric oxide production during infection in vivo FASEB J, July 1, 2000; 14(10): 1447 - 1454. [Abstract] [Full Text] |
||||
![]() |
D. K. Clarke, M. S. Sidhu, J. E. Johnson, and S. A. Udem Rescue of Mumps Virus from cDNA J. Virol., May 15, 2000; 74(10): 4831 - 4838. [Abstract] [Full Text] |
||||
![]() |
E. P. Walsh, M. D. Baron, J. Anderson, and T. Barrett Development of a genetically marked recombinant rinderpest vaccine expressing green fluorescent protein J. Gen. Virol., March 1, 2000; 81(3): 709 - 718. [Abstract] [Full Text] |
||||
![]() |
A. Kato, K. Kiyotani, M. K. Hasan, T. Shioda, Y. Sakai, T. Yoshida, and Y. Nagai Sendai Virus Gene Start Signals Are Not Equivalent in Reinitiation Capacity: Moderation at the Fusion Protein Gene J. Virol., November 1, 1999; 73(11): 9237 - 9246. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Baron, M. Foster-Cuevas, J. Baron, and T. Barrett Expression in cattle of epitopes of a heterologous virus using a recombinant rinderpest virus J. Gen. Virol., August 1, 1999; 80(8): 2031 - 2039. [Abstract] [Full Text] |
||||
![]() |
B. P. H. Peeters, O. S. de Leeuw, G. Koch, and A. L. J. Gielkens Rescue of Newcastle Disease Virus from Cloned cDNA: Evidence that Cleavability of the Fusion Protein Is a Major Determinant for Virulence J. Virol., June 1, 1999; 73(6): 5001 - 5009. [Abstract] [Full Text] |
||||
![]() |
P. Palese RNA virus vectors: Where are we and where do we need to go? PNAS, October 27, 1998; 95(22): 12750 - 12752. [Full Text] [PDF] |
||||
![]() |
T. Shioda, H. Kato, Y. Ohnishi, K. Tashiro, M. Ikegawa, E. E. Nakayama, H. Hu, A. Kato, Y. Sakai, H. Liu, et al. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha ) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage PNAS, May 26, 1998; 95(11): 6331 - 6336. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tapparel, D. Maurice, and L. Roux The Activity of Sendai Virus Genomic and Antigenomic Promoters Requires a Second Element Past the Leader Template Regions: a Motif (GNNNNN)3 Is Essential for Replication J. Virol., April 1, 1998; 72(4): 3117 - 3128. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |